위암 한약제제 임상시험 가이드라인 개발을 위한 한약제제 무작위배정 대조군 임상시험 고찰
= Analysis of Existing Guidelines and Randomized, Controlled, Clinical Trials for Development of [Guideline of Clinical Trial with Herbal Medicinal Product for gastric cancer]
- 저자[authors] 한가진(Gajin Han),성신(Sin Seong),김성수(Sungsu Kim),김진성(Jinsung Kim),박재우(Jae-Woo Park)
- 학술지명[periodical name] 대한한의학회지
- 권호사항[Volume/Issue] Vol.38No.3[2017]
- 발행처[publisher] 대한한의학회
- 자료유형[Document Type] 학술저널
- 수록면[Pagination] 124-142
- 언어[language] Korean
- 발행년[Publication Year] 2017
- KDC[Korean Decimal Classification] 519
- 주제어[descriptor] Stomach neoplasm,herbal medicinal product,Clinical trial,Guideline
초록[abstracts]
[Objectives: This study aimed to learn what should be considered in [Guideline of Clinical Trial with Herbal Medicinal Product for Gastric Cancer)] by analyzing the existing guidelines and clinical trials. Methods: The development committee searched guidelines for herbal medicinal product or gastric cancer developed already. Then, clinical trials for gastric cancer using herbal medicine were searched. The searched trials were analyzed in terms of inclusion and exclusion of participants, intervention, comparator, outcomes and trial design. Then, we compared the results of analysis with the regulations and guidelines of Ministry of Food and Drug Safety to suggest the issue that we will have to consider when making the [Guideline of Clinical Trial with Herbal Medicinal Product for Gastric Cancer]. Results: As a result, few guidelines for anti-tumor agent and clinical trial with herbal medicinal product were searched in the national institution homepage. In addition, 10 articles were searched by using the combination following search term; ‘stomach neoplasm", "herbal medicine’, "Medicine, Korean traditional", ‘Medicine, Chinese Traditional", "TCM", ‘TKM’, ‘trial’. Most trials included gastric cancer participants with medical history of operation. The type of intervention was various such as decoction, granules, and fluid of intravenous injection. Comparators were diverse such as placebo, conventional treatment including chemotherapy and nutritional supplement. The most frequently used outcome for efficacy was quality of life. Besides, the symptom score, tumor response, and survival rate were used. Safety was investigated by recording adverse events. Conclusion: We found out some issue by reviewing the existing guidelines and comparing it with clinical trials for gastric cancer and herbal medicinal products. These results will be utilized for developing [Guideline of Clinical Trial with Herbal Medicinal Product for Gastric Cancer].]
목차[Table of content] 서론 연구방법 및 절차 결과 고찰 참고문헌